# EDGAR Filing Document

**Accession Number:** 0001855129
**File Stem:** 0000950103-23-003702
**Filing Date:** 2023-3
**Character Count:** 2499
**Document Hash:** 7c7202130c6c27335dc27391da3cfe1c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950103-23-003702.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0000950103-23-003702

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230306

**FILED AS OF DATE**: 20230306

**DATE AS OF CHANGE**: 20230306

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GH Research PLC
- **CENTRAL INDEX KEY:** 0001855129
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40530
- **FILM NUMBER:** 23707506

**BUSINESS ADDRESS:**
- **STREET 1:** 28 BAGGOT STREET
- **CITY:** LOWER DUBLIN
- **STATE:** L2
- **ZIP:** 2D02 NX43
- **BUSINESS PHONE:** 353 1 437 8334

**MAIL ADDRESS:**
- **STREET 1:** 28 BAGGOT STREET
- **CITY:** LOWER DUBLIN
- **STATE:** L2
- **ZIP:** 2D02 NX43

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of March, 2023.

**Commission File Number: 001-40530**

**GH Research PLC**

**(Exact name of registrant as specified in its charter)**

**28 Baggot Street Lower<br> Dublin 2**

**D02 NX43**

**Ireland**

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

GH Research PLC (the "Company") will participate in a corporate panel and hold one-on-one investor meetings during the 43<sup>rd</sup> Annual TD Cowen Health Care Conference, which is scheduled to take place from March 6-8, 2023 in Boston, Massachusetts.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **GH Research PLC** | **GH Research PLC** |
| Date: March 6, 2023 |  |  |
|  | By: | /s/ Julie Ryan |
|  | Name: | Julie Ryan |
|  | Title: | Vice President, Finance |

---